AMFm Review and the Financing of Febrile Illness Management

On 17 September, the meeting was focused on The Affordable Medicines Facility-malaria and future scenarios, and on 18 September, the meeting was dedicated to the developing febrile illness management paradigm. The principal investigators of the AMFm independent evaluation, the analysts working on the transition path from AMFm Phase 1, members of the Global Fund and Roll Back Malaria advisory committee, and many experts in febrile illnesses including malaria and pneumonia presented their work and views in this meeting before Global Fund board decisions were taken in November.

Event page

Meeting Agenda

Issue Brief

Tweet #AMFm

Thanks to all who participated in the meeting and to those who followed our feed. Please follow @CDDEP on Twitter for continued updates.